United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
382.77
+5.97 (1.58%)
Nov 5, 2024, 4:00 PM EST - Market closed
United Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$370.86
Upside
-3.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $243 → $302 | Hold | Maintains | $243 → $302 | -21.10% | Nov 1, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $319 → $344 | Strong Buy | Maintains | $319 → $344 | -10.13% | Oct 31, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $575 → $600 | Buy | Maintains | $575 → $600 | +56.75% | Oct 31, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $360 → $400 | Strong Buy | Maintains | $360 → $400 | +4.50% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $425 | Strong Buy | Maintains | $400 → $425 | +11.03% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $350 → $400 | Strong Buy | Maintains | $350 → $400 | +4.50% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $315 → $432 | Strong Buy | Maintains | $315 → $432 | +12.86% | Sep 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $400 → $575 | Buy | Maintains | $400 → $575 | +50.22% | Aug 28, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $350 → $380 | Buy | Maintains | $350 → $380 | -0.72% | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +4.50% | Aug 1, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $303 → $280 | Sell | Maintains | $303 → $280 | -26.85% | Aug 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $300 → $400 | Strong Buy | Maintains | $300 → $400 | +4.50% | Jul 25, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $270 → $350 | Strong Buy | Maintains | $270 → $350 | -8.56% | Jul 11, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $310 → $321 | Buy → Hold | Downgrades | $310 → $321 | -16.14% | Jul 11, 2024 |
| UBS | UBS | Strong Buy Maintains $300 → $370 | Strong Buy | Maintains | $300 → $370 | -3.34% | Jul 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $325 → $350 | Buy | Maintains | $325 → $350 | -8.56% | Jun 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.